TY  - GEN
N2  - There is a growing national demand to demonstrate quality of care, efficacious clinical  outcomes and evidence based practice.  Enhanced by Center for Medicare/Medicaid Services (CMS) discussion of outcome based reimbursement and the need for fiscal restraint on what many see as the unsustainable trajectory of health care costs demand is growing to develop new methods of measurement of health care and clinical outcomes. Quality of life (QoL) has been discussed conceptually for many years but has been thrust further  into clinical consciousness with this discussion. In summary, there is a need for a simple but comprehensive, standardized tool that can be used as a metric for the impact of pituitary tumors on QoL and life function changes. After validation, this instrument could be used to guide decision making with respect to choice and  timing of treatments and to compare the efficacy of different treatment modalities or specific  treatments over time and correlate clinical findings in pituitary diseases. Such a tool is needed to  guide assessment, informed consent and treatment in both specialty care and primary care  settings and to demonstrate efficacious outcomes of care.
DO  - 10.6083/M4Q52MMB
DO  - DOI
AB  - There is a growing national demand to demonstrate quality of care, efficacious clinical  outcomes and evidence based practice.  Enhanced by Center for Medicare/Medicaid Services (CMS) discussion of outcome based reimbursement and the need for fiscal restraint on what many see as the unsustainable trajectory of health care costs demand is growing to develop new methods of measurement of health care and clinical outcomes. Quality of life (QoL) has been discussed conceptually for many years but has been thrust further  into clinical consciousness with this discussion. In summary, there is a need for a simple but comprehensive, standardized tool that can be used as a metric for the impact of pituitary tumors on QoL and life function changes. After validation, this instrument could be used to guide decision making with respect to choice and  timing of treatments and to compare the efficacy of different treatment modalities or specific  treatments over time and correlate clinical findings in pituitary diseases. Such a tool is needed to  guide assessment, informed consent and treatment in both specialty care and primary care  settings and to demonstrate efficacious outcomes of care.
AD  - Oregon Health and Science University
T1  - Clinical inquiry project: domains of life function scale for patients with pituitary adenomas
DA  - 2011
AU  - Yedinak, Christine
L1  - https://digitalcollections.ohsu.edu/record/690/files/691_etd.pdf
PB  - Oregon Health and Science University
PY  - 2011
ID  - 690
L4  - https://digitalcollections.ohsu.edu/record/690/files/691_etd.pdf
KW  - Advanced Practice Nursing
KW  - Pituitary Gland
KW  - Quality of Life
KW  - Nurse Anesthetists
KW  - Nursing
KW  - Research
KW  - Clinical Nursing Research
KW  - Pituitary Neoplasms
KW  - Midwifery
KW  - Evidence-Based Nursing
KW  - clinical inquiry report
KW  - tumors
KW  - outcome assessment (medical care)
KW  - outcome assessment (health care)
KW  - case reports
KW  - nurse practioners
TI  - Clinical inquiry project: domains of life function scale for patients with pituitary adenomas
Y1  - 2011
L2  - https://digitalcollections.ohsu.edu/record/690/files/691_etd.pdf
LK  - https://digitalcollections.ohsu.edu/record/690/files/691_etd.pdf
UR  - https://digitalcollections.ohsu.edu/record/690/files/691_etd.pdf
ER  -